1 hour ago
1
mediaphotos/iStock via Getty Images
Indivior (NASDAQ:INDV) announced on Tuesday that it is exploring strategic options for its nasal opioid overdose treatment, Opvee, as well as its international operations.
In a recent filing, the company revealed it has initiated a series of operational changes aimed at
© FBT Company 2025. All rights are reserved
English (US) ·